Literature DB >> 12734909

Aerobic exercise capacity in patients with juvenile dermatomyositis.

Tim Takken1, Naomi Spermon, Paul J M Helders, A Berent J Prakken, Janjaap Van Der Net.   

Abstract

OBJECTIVE: To examine the feasibility of maximum exercise testing in patients with juvenile dermatomyositis (JDM), characterize the maximum oxygen consumption (VO2peak) of these patients, and determine if exercise time could be used as an surrogate index for VO2peak.
METHODS: Fifteen patients diagnosed with JDM (age 5-14) performed a graded, maximum exercise test using a motor driven treadmill and metabolic cart to volitional exhaustion conforming to the Bruce protocol.
RESULTS: All patients were able to perform the exercise test. Ten of the 15 patients performed a maximal effort (heart rate > 180 beats/min or respiratory exchange ratio > 1.0). The patients who had a maximal exercise performance, the mean absolute VO2peak, relative VO2peak (related to body mass), and exercise time were respectively -1.82 (+/- 1.5), -2.83 (+/- 1.9), and -3.65 (+/- 1.9) standard deviations lower compared to age and sex matched reference values (p < 0.05). Z scores for exercise time were significantly lower compared to Z scores for absolute and relative VO2peak, an indication of reduced muscular economy. When exercise time was converted to VO2peak using the equation: VO2peak = 0.1583 (exercise time) + 0.0828, the VO2peak values were not significantly different from the measured VO2peak values.
CONCLUSION: Aerobic exercise testing on a treadmill was possible in patients with JDM and revealed an impairment in their maximal aerobic exercise capacity. Exercise time can be used as an indicator of VO2peak, when converted to VO2peak using a regression equation. VO2peak, measured or estimated, has the potential to be a good indicator of muscle function in patients with JDM.

Entities:  

Mesh:

Year:  2003        PMID: 12734909

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 2.  Physical activity for paediatric rheumatic diseases: standing up against old paradigms.

Authors:  Bruno Gualano; Eloisa Bonfa; Rosa M R Pereira; Clovis A Silva
Journal:  Nat Rev Rheumatol       Date:  2017-05-23       Impact factor: 20.543

Review 3.  Exercise in inflammatory myopathies, including inclusion body myositis.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 4.  Paediatric idiopathic inflammatory muscle disease: recognition and management.

Authors:  Clarissa A Pilkington; Lucy R Wedderburn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review.

Authors:  Rossella Talotta; Irene Porrello; Roberto Restuccia; Ludovico Magaudda
Journal:  Clin Rheumatol       Date:  2021-10-19       Impact factor: 2.980

6.  Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis.

Authors:  Esther A Habers; Marco van Brussel; Anneli C Langbroek-Amersfoort; Annet van Royen-Kerkhof; Tim Takken
Journal:  BMC Musculoskelet Disord       Date:  2012-06-21       Impact factor: 2.362

7.  Responsiveness to exercise training in juvenile dermatomyositis: a twin case study.

Authors:  Clarissa Omori; Danilo M L Prado; Bruno Gualano; Adriana M E Sallum; Ana L Sá-Pinto; Hamilton Roschel; Maria B Perondi; Clovis A A Silva
Journal:  BMC Musculoskelet Disord       Date:  2010-11-25       Impact factor: 2.362

Review 8.  Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

Authors:  Djamilla K D van der Stap; Lisa G Rider; Helene Alexanderson; Adam M Huber; Bruno Gualano; Patrick Gordon; Janjaap van der Net; Pernille Mathiesen; Liam G Johnson; Floranne C Ernste; Brian M Feldman; Kristin M Houghton; Davinder Singh-Grewal; Abraham Garcia Kutzbach; Li Alemo Munters; Tim Takken
Journal:  J Rheumatol       Date:  2015-11-15       Impact factor: 4.666

9.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomine A van Pelt; Tim Takken; Marco van Brussel; Mirjam de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-20       Impact factor: 3.054

10.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomien A van Pelt; Tim Takken; Marco van Brussel; Inge de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-27       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.